According to our new research study on “Non-Invasive Aesthetic Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Procedure and End User,” the market is expected to reach US$ 18,656.54 million by 2028 from US$ 6,504.19 million in 2020; it is estimated to grow at a CAGR of 14.2% from 2021 to 2028. The report highlights trends prevailing in the market, and the factors driving and hindering the non-invasive aesthetic treatment market growth. The rising number of non-invasive aesthetic/cosmetic procedures performed every year, surge in awareness about cosmetic procedures among consumers, and availability of technologically advanced products are among the major forces boosting the market growth. However, clinical risks and complications associated with medical aesthetic procedures are limiting the market growth.

Get Your Free Sample Copy Today | Click Here: https://www.theinsightpartners.com/sample/TIPRE00022432

Non-invasive or non-surgical aesthetic treatment procedures do not involve any surgical incision. In some cases, minimally invasive surgeries are also considered as non-surgical procedures. A few of the commonly conducted non-invasive aesthetic treatments include botulinum toxin injection, chemical peels, non-surgical laser treatment, and microdermabrasion. Based on end user, the non-invasive aesthetic treatment market is segmented into hospitals, clinics and medical spas, and others. In 2020, the hospitals segment held the largest share of the market; it is further estimated to register the highest CAGR of 14.9% during the forecast period.

The non-invasive aesthetic treatment market is witnessing slump amid the COVID-19 pandemic. Most healthcare research organizations and hospitals are engaged in introducing new products and solutions for the effective management of the disease. In addition, governments have issued guidelines for the rescheduling or suspension of all elective surgeries with an aim to focus completely on handling the COVID-19 pandemic. This is hampering the demand for non-invasive aesthetic treatments, thus limiting the market growth.

Galderma SA, Alma Lasers, Merz Pharma, Bausch Health Companies Inc., Cutera Inc., Revance Therapeutics Inc., Cynosure, AbbVie Inc., Candela Medical, and Johnson and Johnson Services, Inc. are among the leading companies operating in the non-invasive aesthetic treatment market.

The report segments non-invasive aesthetic treatment market as follows:

By Procedure

•          Injectables

o          Botulinum Toxin

o          Calcium Hydroxyapatite

o          Hyaluronic Acid

o          Polymer Filler

o          Collagen

•          Skin Rejuvenation

o          Chemical Peel

o          Laser Skin Resurfacing

o          Photorejuvenation

•          Others

o          Hair Removal

o          Nonsurgical Fat Reduction

o          Sclerotherapy

o          Cellulite Treatment

By End User

•          Hospitals

•          Clinics and Medical Spas

•          Others

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Non-Invasive Aesthetic Treatment, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Ankit Mathur

Phone : +1-646-491-9876

E-mail : [email protected]

About The Author